- Founded
- 2014
- Stage
- Seed
- Invested
- 2014
- Status
- Private
Karius is a life sciences company transforming infectious disease diagnostics with genomics. It began with work on microbial cell-free DNA at Stanford University and was inspired by one child’s story. The Karius® Test is a comprehensive tool capable of identifying more than 1,000 pathogens directly from blood. With this next-generation sequencing-based test, we are helping clinicians improve patient outcomes and helping industry accelerate drug development.